Skip to main content

Prescription medicine

Iothalamate sodium i 125 First approved as Glofil-125

Iothalamate sodium i 125 (Glofil-125) is a prescription medicine with an FDA approval on record since 1974. No generic is listed in FDA's NDC Directory.

  • No generic listed

Check it at the source: the iothalamate sodium i 125 FDA label on DailyMed (effective December 9, 2019, Iso-Tex Diagnostics, Inc.); the NDA 17279 record on Drugs@FDA; every iothalamate sodium i 125 label on DailyMed.

Highlights of the record

FDA label of December 9, 2019; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage

GLOFIL-125 (Sodium Iothalamate I-125 Injection) is indicated for evaluation of glomerular filtration in the diagnosis or monitoring of patients with renal disease.

Forms and strengths

Injection (solution).

On the market

Earliest approval on file
February 12, 1974 Glofil-125, Isotex; Drugs@FDA’s file, where older or withdrawn approvals can be missing
Generic approvals
No generic approved
Labelers listed (NDC)
1 of which 0 under generic applications, 1 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
Not in the survey
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
No recall recorded

What is iothalamate sodium i 125 used for?

From the label: indications and usage

GLOFIL-125 (Sodium Iothalamate I-125 Injection) is indicated for evaluation of glomerular filtration in the diagnosis or monitoring of patients with renal disease.

FDA pharmacologic class: Radioactive Diagnostic Agent.

Source: FDA drug label (Glofil-125), NDA017279 (Isotex), as published by Iso-Tex Diagnostics, Inc., effective December 9, 2019 (SPL set 7f250086-2837-484b-9674-e09856b34cb0), via openFDA; the full label on DailyMed

Is there a generic for iothalamate sodium i 125 (Glofil-125)?

No generic iothalamate sodium i 125 is approved (Drugs@FDA, October 8, 2026).

  • 1974 earliest approval on file

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What next?

Other radioactive diagnostic agents
the pharmacologic class, with prices and generics
Check an interaction
what two or more labels say about each other